Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 23

How to Read Drug Quality Certificates for Indian Generic Medicines: A 2026 Buyer’s Guide

  • Post published:July 15, 2026
  • Post category:Knowledge

When buying generic medicines from India, verifying the quality and authenticity of the products is paramount. Unlike brand-name drugs, generics rely on documented evidence of bioequivalence, Good Manufacturing Practices (GMP),…

Continue Reading How to Read Drug Quality Certificates for Indian Generic Medicines: A 2026 Buyer’s Guide

India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%

  • Post published:July 14, 2026
  • Post category:News

The Indian pharmaceutical sector enters the second half of 2026 with significant momentum as three major developments converge: the India-UK Comprehensive Economic Trade Agreement (CETA) taking effect on July 15,…

Continue Reading India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%

Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide

  • Post published:July 5, 2026
  • Post category:Knowledge

For international buyers, healthcare professionals, and procurement specialists, navigating the quality assurance landscape of generic medicines can be complex. One of the most globally recognized benchmarks for pharmaceutical quality is…

Continue Reading Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide

Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026

  • Post published:July 4, 2026
  • Post category:News

India's pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early…

Continue Reading Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
  • Go to the previous page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 31
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve